<DOC>
	<DOCNO>NCT00409773</DOCNO>
	<brief_summary>A 6-week clinical trial patient metabolic syndrome hypercholesterolemia high risk coronary heart disease study effect ezetimibe/simvastatin atorvastatin lipid .</brief_summary>
	<brief_title>Ezetimibe/Simvastatin Patients With Metabolic Syndrome ( 0653A-107 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patients 18 79 year age metabolic syndrome hypercholesterolemia high risk coronary heart disease ( CHD ) LDLC 70 mg/dL 100 mg/dL depend CHD risk category A condition , opinion investigator , pose risk patient interfere participate study Patient likely great 20 % noncompliant take study medication Patients chronic medical condition Patients unstable dos medication Pregnant lactate woman , woman intend become pregnant Patient currently receive prescription therapy statins lipidaltering medication Patient Type 1 Type 2 diabetes mellitus poorly control , newly diagnose , take new recently adjust antidiabetic pharmacotherapy ( exception +/ 10 unit insulin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>